Patents by Inventor Marc Issandou

Marc Issandou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of using SCAP antagonists
    Patent number: 6673555
    Abstract: The invention relates to a method for screening therapeutic agents, defined as SCAP antagonists, for use in combating diseases associated with elevated lipid levels, said method comprising detecting or assaying the extent or result of transcriptional activity or binding between a control SCAP antagonist and SCAP, in the presence of and absence of said agent. Also claimed are therapeuic agents which are antagonists of SCAP, identified by such a method and their use in combating diseases associated with elevated lipid levels.
    Type: Grant
    Filed: July 13, 2000
    Date of Patent: January 6, 2004
    Assignee: SmithKline Beecham Corporation
    Inventors: Thierry André Régis Grand-Perrett, Marc Issandou
  • Pharmaceutical compositions
    Publication number: 20030224347
    Abstract: The invention relates to a method for screening therapeutic agents, defined as SCAP antagonists, for use in combating diseases associated with elevated lipid levels, said method comprising detecting or assaying the extent or result of transcriptional activity or binding between a control SCAP antagonist and SCAP, in the presence of and absence of said agent. Also claimed are therapeuic agents which are antagonists of SCAP, identified by such a method and their use in combating diseases associated with elevated lipid levels.
    Type: Application
    Filed: May 20, 2003
    Publication date: December 4, 2003
    Inventors: Thierry Andre Regis Grand-Perret, Marc Issandou
  • Methods of screening for SCAP antagonists
    Publication number: 20030224348
    Abstract: The invention relates to a method for screening therapeutic agents, defined as SCAP antagonists, for use in combating diseases associated with elevated lipid levels, said method comprising detecting or assaying the extent or result of transcriptional activity or binding between a control SCAP antagonist and SCAP, in the presence of and absence of said agent. Also claimed are therapeuic agents which are antagonists of SCAP, identified by such a method and their use in combating diseases associated with elevated lipid levels.
    Type: Application
    Filed: May 20, 2003
    Publication date: December 4, 2003
    Inventors: Thierry Andre Regis Grand-Perret, Marc Issandou